About Hyris
Hyris is a company based in London (United Kingdom) founded in 2014.. Hyris has raised $2.84 million across 2 funding rounds from investors including Indena, Astanor and NEOS Medica. Hyris offers products and services including Hyris System™, qPCR Devices, and AI Software. Hyris operates in a competitive market with competitors including Parse Biosciences, Biofidelity, RareCyte, Qiagen and RainDance, among others.
- Headquarter London, United Kingdom
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Hyris Limited
- Date of Incorporation 05 Nov, 2014
- Jurisdiction LONDON, UNITED KINGDOM
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$2.84 M (USD)
in 2 rounds
-
Latest Funding Round
$2.84 M (USD), Series A
Jun 09, 2020
-
Investors
Indena
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Hyris
Hyris offers a comprehensive portfolio of products and services, including Hyris System™, qPCR Devices, and AI Software. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Multi-market platform for genetic testing and marketplace transactions
Miniaturized devices for superior genetic analysis performance
Cloud-based platform for operating and gaining testing insights
Unlock access to complete
Funding Insights of Hyris
Hyris has successfully raised a total of $2.84M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $2.84 million completed in June 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $2.8M
-
First Round
First Round
(21 Jul 2017)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2020 | Amount | Series A - Hyris | Valuation | Astanor | |
| Jul, 2017 | Amount | Grant - Hyris | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Hyris
Hyris has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Indena, Astanor and NEOS Medica. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Astanor is focused on transforming the agrifood system through investments.
|
Founded Year | Domain | Location | |
|
Early-stage AI startups are funded and supported by Pi Campus.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Hyris
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Hyris
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Hyris Comparisons
Competitors of Hyris
Hyris operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Parse Biosciences, Biofidelity, RareCyte, Qiagen and RainDance, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
RNA-sequencing transcriptome kits for health data analysis are developed.
|
|
| domain | founded_year | HQ Location |
Molecular diagnostic assays are developed for target DNA sequence detection.
|
|
| domain | founded_year | HQ Location |
Developer of technologies for the analysis of rare and single cells in the blood
|
|
| domain | founded_year | HQ Location |
Products and reagents for molecular diagnostic assays are supplied.
|
|
| domain | founded_year | HQ Location |
Developer of nucleic acid detection and quantification systems
|
|
| domain | founded_year | HQ Location |
Immuno-sequencing products are developed for disease diagnostics and treatment.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Hyris
Frequently Asked Questions about Hyris
When was Hyris founded?
Hyris was founded in 2014 and raised its 1st funding round 3 years after it was founded.
Where is Hyris located?
Hyris is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Who is the current CEO of Hyris?
Stefano Lo Priore is the current CEO of Hyris.
Is Hyris a funded company?
Hyris is a funded company, having raised a total of $2.84M across 2 funding rounds to date. The company's 1st funding round was a Grant of $11.56K, raised on Jul 21, 2017.
What does Hyris do?
Hyris was founded in 2014 in London, United Kingdom. An integrated platform for genetic testing of biological samples has been developed, featuring the compact bCUBE 2.0 for data analysis. Real-time results are recorded on the cloud-based Hyris bAPP, which controls the platform for Real-Time PCR and isothermal protocols. Services are extended to the medical, veterinary, and agrofood sectors through this technology.
Who are the top competitors of Hyris?
Hyris's top competitors include Qiagen, Parse Biosciences and NuProbe.
What products or services does Hyris offer?
Hyris offers Hyris System™, qPCR Devices, and AI Software.
Who are Hyris's investors?
Hyris has 5 investors. Key investors include Indena, Astanor, NEOS Medica, Pi Campus, and UniCredit Start Lab.